Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Breast Cancer Disparities and the COVID-19 Pandemic

Breast Cancer Disparities and the COVID-19 Pandemic Purpose of ReviewThe COVID-19 pandemic has placed unprecedented challenges on breast cancer patients and health care providers. The impact of the pandemic on preexisting breast cancer disparities remains unknown but is projected to have adverse outcomes.Recent FindingsEarly work has demonstrated that pandemic-related temporary suspensions in breast cancer screening, interruption of clinical trials, and treatment delays have an adverse impact on breast cancer patient outcomes and may worsen disparities.SummaryIn this review, we highlight existing knowledge regarding breast cancer disparities and the impact of the COVID-19 pandemic. Strategies for mitigating disparities moving forward include targeted research evaluating race-specific outcomes, targeted education for providers regarding breast health disparities, improved access to telehealth, maintenance of patient navigation programs, and patient education regarding the safety and necessity of enrollment in clinical trials. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Breast Cancer Reports Springer Journals

Breast Cancer Disparities and the COVID-19 Pandemic

Download PDF
7 pages

Loading next page...
 
/lp/springer-journals/breast-cancer-disparities-and-the-covid-19-pandemic-1AEGwS2riS
Publisher
Springer Journals
Copyright
Copyright © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
ISSN
1943-4588
eISSN
1943-4596
DOI
10.1007/s12609-022-00458-y
Publisher site
See Article on Publisher Site

Abstract

Purpose of ReviewThe COVID-19 pandemic has placed unprecedented challenges on breast cancer patients and health care providers. The impact of the pandemic on preexisting breast cancer disparities remains unknown but is projected to have adverse outcomes.Recent FindingsEarly work has demonstrated that pandemic-related temporary suspensions in breast cancer screening, interruption of clinical trials, and treatment delays have an adverse impact on breast cancer patient outcomes and may worsen disparities.SummaryIn this review, we highlight existing knowledge regarding breast cancer disparities and the impact of the COVID-19 pandemic. Strategies for mitigating disparities moving forward include targeted research evaluating race-specific outcomes, targeted education for providers regarding breast health disparities, improved access to telehealth, maintenance of patient navigation programs, and patient education regarding the safety and necessity of enrollment in clinical trials.

Journal

Current Breast Cancer Reports – Springer Journals

Published: Dec 1, 2022

Keywords: Breast cancer; Health disparities; COVID-19 pandemic; Breast cancer disparities; Social determinants of health

References

  • Breast cancer statistics, 2019
    DeSantis, CE; Ma, J; Gaudet, MM; Newman, LA; Miller, KD; Goding Sauer, A
  • Racial disparities in screening mammography in the United States: a systematic review and meta-analysis
    Ahmed, AT; Welch, BT; Brinjikji, W; Farah, WH; Henrichsen, TL; Murad, MH
  • Inherited predisposition to breast cancer among African American women
    Churpek, JE; Walsh, T; Zheng, Y; Moton, Z; Thornton, AM; Lee, MK
  • Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast cancer
    Behrendt, CE; Hurria, A; Tumyan, L; Niland, JC; Mortimer, JE
  • Cancer disparities and Black American representation in clinical trials leading to the approval of oral chemotherapy drugs in the United States between 2009 and 2019
    Ajewole, VB; Akindele, O; Abajue, U; Ndulue, O; Marshall, JJ; Mossi, YT
  • Breast cancer through the lens of the COVID-19 pandemic
    Newman, L; Fejerman, L; Pal, T; Mema, E; McGinty, G; Cheng, A
  • Disparities in cancer outcomes due to COVID-19-a tale of 2 cities
    Balogun, OD; Bea, VJ; Phillips, E
  • Disparities in cancer prevention in the COVID-19 era
    Carethers, JM; Sengupta, R; Blakey, R; Ribas, A; D'Souza, G
  • The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
    Maringe, C; Spicer, J; Morris, M; Purushotham, A; Nolte, E; Sullivan, R
  • Socioeconomic and racial inequities in breast cancer screening during the COVID-19 pandemic in Washington state
    Amram, O; Robison, J; Amiri, S; Pflugeisen, B; Roll, J; Monsivais, P
  • Trends in breast cancer screening in a safety-net hospital during the COVID-19 pandemic
    Velazquez, AI; Hayward, JH; Gregory, B; Dixit, N
  • COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States
    DeGroff, A; Miller, J; Sharma, K; Sun, J; Helsel, W; Kammerer, W
  • Identifying patients at risk of delayed breast imaging due to the COVID-19 pandemic
    Li, S; O'Brien, S; Murphy, C; Nabil, C
  • Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors
    Miller, MM; Meneveau, MO; Rochman, CM; Schroen, AT; Lattimore, CM; Gaspard, PA
  • Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all
    Newman, LA; Roff, NK; Weinberg, AD
  • Reducing racial disparities in breast cancer survivors’ ratings of quality cancer care: the enduring impact of trust
    Sheppard, VB; Hurtado-de-Mendoza, A; Talley, CH; Zhang, Y; Cabling, ML; Makambi, KH
  • The impact of COVID-19 on clinical trials
    Asaad, M; Habibullah, NK; Butler, CE
  • Management of cancer surgery cases during the COVID-19 pandemic: considerations
    Bartlett, DL; Howe, JR; Chang, G; Crago, A; Hogg, M; Karakousis, G
  • Physician peer group characteristics and timeliness of breast cancer surgery
    Bachand, J; Soulos, PR; Herrin, J; Pollack, CE; Xu, X; Ma, X
  • Does a multidisciplinary approach to invasive breast cancer care improve time to treatment and patient compliance?
    Doe, S; Petersen, S; Buekers, T; Swain, M
  • Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women
    Emerson, MA; Golightly, YM; Aiello, AE; Reeder-Hayes, KE; Tan, X; Maduekwe, U
  • Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities
    Hoppe, EJ; Hussain, LR; Grannan, KJ; Dunki-Jacobs, EM; Lee, DY; Wexelman, BA
  • Racial disparities in low-value surgical care and time to surgery in high-volume hospitals
    Jackson, DK; Li, Y; Eskander, MF; Tsung, A; Oppong, BA; Bhattacharyya, O
  • Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls
    Rentscher, KE; Zhou, X; Small, BJ; Cohen, HJ; Dilawari, AA; Patel, SK